Revenue by source
Medical Devices$21.39BDiagnostic Products$8.94BNutritional Products$8.45BEstablished Pharmaceutical Products$5.54BProprietary Pharmaceutical Products$0.00Unallocated Amount to Segment$0.00Vascular Products$0.00
| Segment | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Medical Devices | - | - | - | - | - | - | $8.91B | $9.44B | $12.24B | $11.79B | $14.37B | $14.69B | $16.89B | $18.99B | $21.39B |
| Diagnostic Products | $4.13B | $4.29B | $4.55B | $4.72B | $4.65B | $4.81B | $5.62B | $7.50B | $7.71B | $10.81B | $15.64B | $16.58B | $9.99B | $9.34B | $8.94B |
| Nutritional Products | $6.01B | $6.47B | $6.74B | $6.95B | $6.98B | $6.90B | $6.93B | $7.23B | $7.41B | $7.65B | $8.29B | $7.46B | $8.15B | $8.41B | $8.45B |
| Established Pharmaceutical Products | $5.41B | $5.12B | $4.97B | $3.12B | $3.72B | $3.86B | $4.29B | $4.42B | $4.49B | $4.30B | $4.72B | $4.91B | $5.07B | $5.19B | $5.54B |
| Proprietary Pharmaceutical Products | $17.02B | $18.01B | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Unallocated Amount to Segment | $2.95B | $2.91B | $2.58B | $2.47B | $2.27B | $2.39B | $1.65B | $2.00B | $57.00M | $66.00M | - | - | - | - | - |
| Vascular Products | $3.33B | $3.07B | $3.01B | $2.99B | $2.79B | $2.90B | - | - | - | - | - | - | - | - | - |
Revenue by country
UNITED STATES$17.13BNon-US$15.98BC [N]$1.91BD [E]$2.76BJ [P]$1.48BI [N]$1.87BC [H]$1.87BN [L]$0.00CANADA$0.00I [T]$0.00F [R]$0.00R [U]$0.00B [R]$0.00G [B]$0.00SPAIN$0.00V [N]$0.00C [O]$0.00
| Segment | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| UNITED STATES | $15.19B | $16.01B | $16.78B | $6.27B | $6.12B | $6.27B | $6.49B | $9.67B | $10.84B | $11.40B | $13.02B | $16.64B | $18.14B | $15.45B | $16.32B | $17.13B |
| Non-US | $19.97B | $22.84B | $10.56B | $5.28B | $5.17B | $4.88B | $4.99B | $5.74B | $11.22B | $11.53B | $12.58B | $15.52B | $14.84B | $14.08B | $14.85B | $15.98B |
| C [N] | - | - | - | $1.08B | $1.32B | $1.80B | $1.73B | $2.15B | $2.31B | $2.35B | $1.97B | $2.39B | $2.13B | $2.25B | $2.11B | $1.91B |
| D [E] | - | - | $1.74B | $1.07B | $978.00M | $1.00B | $1.04B | $1.37B | $1.62B | $1.75B | $2.11B | $2.57B | $2.34B | $2.35B | $2.54B | $2.76B |
| J [P] | - | - | $2.44B | $1.44B | $968.00M | $895.00M | $924.00M | $1.26B | $1.33B | $1.44B | $1.39B | $1.70B | $1.93B | $1.51B | $1.44B | $1.48B |
| I [N] | - | - | $933.00M | $922.00M | $1.01B | $1.05B | $1.11B | $1.24B | $1.33B | $1.40B | $1.32B | $1.56B | $1.65B | $1.75B | $1.82B | $1.87B |
| C [H] | - | - | - | $792.00M | $707.00M | $784.00M | $766.00M | $841.00M | $1.01B | $1.07B | $1.14B | $1.31B | $1.34B | $1.64B | $1.75B | $1.87B |
| N [L] | - | - | $1.88B | $960.00M | $788.00M | $855.00M | $830.00M | $929.00M | $930.00M | $975.00M | $1.08B | - | - | $1.07B | $1.12B | - |
| CANADA | - | - | $1.25B | $734.00M | - | - | - | - | - | - | - | $1.39B | $1.28B | - | - | - |
| I [T] | - | - | $1.13B | $726.00M | $436.00M | $383.00M | $365.00M | $507.00M | - | - | - | - | - | - | - | - |
| F [R] | - | - | $1.17B | $680.00M | $488.00M | $375.00M | - | $628.00M | - | - | - | - | - | - | - | - |
| R [U] | - | - | - | $525.00M | $536.00M | $483.00M | $554.00M | $664.00M | - | - | - | - | - | - | - | - |
| B [R] | - | - | - | $470.00M | $508.00M | $381.00M | $410.00M | $541.00M | - | - | - | - | - | - | - | - |
| G [B] | - | - | - | - | $447.00M | $430.00M | $377.00M | $498.00M | - | - | - | - | - | - | - | - |
| SPAIN | - | - | $942.00M | $413.00M | $310.00M | - | - | - | - | - | - | - | - | - | - | - |
| V [N] | - | - | - | - | - | - | $434.00M | - | - | - | - | - | - | - | - | - |
| C [O] | - | - | - | - | - | - | $424.00M | - | - | - | - | - | - | - | - | - |